{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T02:13:41Z","timestamp":1782267221925,"version":"3.54.5"},"reference-count":116,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,22]],"date-time":"2013-07-22T00:00:00Z","timestamp":1374451200000},"content-version":"vor","delay-in-days":782,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.canlet.2011.02.007","type":"journal-article","created":{"date-parts":[[2011,3,13]],"date-time":"2011-03-13T08:37:41Z","timestamp":1300005461000},"page":"175-185","source":"Crossref","is-referenced-by-count":73,"title":["HIV, EBV and KSHV: Viral cooperation in the pathogenesis of human malignancies"],"prefix":"10.1016","volume":"305","author":[{"given":"Suzane","family":"Ramos da Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deilson","family":"Elgui de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2011.02.007_b0005","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/sj.cr.7290372","article-title":"AIDS and associated malignancies","volume":"15","author":"Wood","year":"2005","journal-title":"Cell Res."},{"key":"10.1016\/j.canlet.2011.02.007_b0010","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.canlet.2006.05.010","article-title":"DNA viruses in human cancer: an integrated overview on fundamental mechanisms of viral carcinogenesis","volume":"247","author":"Elgui de Oliveira","year":"2007","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2011.02.007_b0015","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissue (IARC WHO Classification of Tumours)","author":"Swerdlow","year":"2008"},{"key":"10.1016\/j.canlet.2011.02.007_b0020","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1146\/annurev.pathol.1.110304.100133","article-title":"KSHV infection and the pathogenesis of Kaposi\u2019s sarcoma","volume":"1","author":"Ganem","year":"2006","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.canlet.2011.02.007_b0025","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1056\/NEJM199505043321802","article-title":"Kaposi\u2019s Sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas","volume":"332","author":"Cesarman","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2011.02.007_b0030","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1136\/jcp.2007.051953","article-title":"HIV infection and lymphoma","volume":"60","author":"Grogg","year":"2007","journal-title":"J. Clin.Pathol."},{"key":"10.1016\/j.canlet.2011.02.007_b0035","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0140-6736(90)90001-L","article-title":"Kaposi\u2019s sarcoma among persons with AIDS: a sexually transmitted infection?","volume":"335","author":"Beral","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.canlet.2011.02.007_b0040","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1086\/315503","article-title":"Interaction of human immunodeficiency virus type 1 and human herpesvirus type 8 infections on the incidence of Kaposi\u2019s sarcoma","volume":"181","author":"Jacobson","year":"2000","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.canlet.2011.02.007_b0045","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1136\/bmj.319.7201.23","article-title":"Risk of HIV related Kaposi\u2019s sarcoma and non-Hodgkin\u2019s lymphoma with potent antiretroviral therapy: prospective cohort study","volume":"319","author":"Ledergerber","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/j.canlet.2011.02.007_b0050","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/00002030-200103300-00013","article-title":"Decreasing rates of Kaposi\u2019s sarcoma and non-Hodgkin\u2019s lymphoma in the era of potent combination anti-retroviral therapy","volume":"15","author":"Grulich","year":"2001","journal-title":"AIDS"},{"key":"10.1016\/j.canlet.2011.02.007_b0055","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/S0959-8049(01)00104-6","article-title":"AIDS and cancer in the era of highly active antiretroviral therapy (HAART)","volume":"37","author":"Rabkin","year":"2001","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.canlet.2011.02.007_b0060","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1182\/blood.V98.8.2339","article-title":"Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy","volume":"98","author":"Besson","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2011.02.007_b0065","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/CCO.0b013e3282c8c90d","article-title":"AIDS-defining and non-AIDS-defining malignancies: cancer occurrence in the antiretroviral therapy era","volume":"19","author":"Silverberg","year":"2007","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.canlet.2011.02.007_b0070","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1097\/00002030-200209060-00014","article-title":"The incidence of lymphoma in the UK haemophilia population between 1978 and 1999","volume":"16","author":"Wilde","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.canlet.2011.02.007_b0075","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1093\/jnci\/92.22.1823","article-title":"Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults","volume":"92","author":"International Collaboration on HIV and Cancer","year":"2000","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.canlet.2011.02.007_b0080","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/cncr.21562","article-title":"Changes in acquired immunodeficiency syndrome-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: incidence, presentation, treatment, and survival","volume":"106","author":"Diamond","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2011.02.007_b0085","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1097\/00002030-200205030-00005","article-title":"High Epstein\u2013Barr virus (EBV) DNA loads in HIV-infected patients: correlation with antiretroviral therapy and quantitative EBV serology","volume":"16","author":"Stevens","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.canlet.2011.02.007_b0090","first-page":"42","article-title":"Defining a role for antiviral drugs in the treatment of persons with HHV-8 infection","volume":"13","author":"Casper","year":"2006","journal-title":"Herpes"},{"key":"10.1016\/j.canlet.2011.02.007_b0095","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/00002030-200402200-00015","article-title":"Short- and long-term effects of highly active antiretroviral therapy on Kaposi sarcoma-associated herpesvirus immune responses and viraemia","volume":"18","author":"Bourboulia","year":"2004","journal-title":"AIDS"},{"key":"10.1016\/j.canlet.2011.02.007_b0100","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/00126334-200212010-00003","article-title":"Prospective study of the effects of antiretroviral therapy on Kaposi sarcoma \u2013 associated herpesvirus infection in patients with and without Kaposi sarcoma","volume":"31","author":"Gill","year":"2002","journal-title":"J. Acquir. Immune Deficiency Syndromes"},{"key":"10.1016\/j.canlet.2011.02.007_b0105","first-page":"44","article-title":"Acquired immunodeficiency syndrome-related Kaposi\u2019s sarcoma regression after highly active antiretroviral therapy: biologic correlates of clinical outcome","volume":"28","author":"Cattelan","year":"2001","journal-title":"J. Natl. Cancer Inst. Monogr."},{"key":"10.1016\/j.canlet.2011.02.007_b0110","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1016\/S0959-8049(99)00161-6","article-title":"Regression of AIDS-related Kaposi\u2019s sarcoma following antiretroviral therapy with protease inhibitors: biological correlates of clinical outcome","volume":"35","author":"Cattelan","year":"1999","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.canlet.2011.02.007_b0115","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.4049\/jimmunol.175.3.2010","article-title":"Reconstitution of EBV latent but not lytic antigen-specific CD4+ and CD8+ T cells after HIV treatment with highly active antiretroviral therapy","volume":"175","author":"Piriou","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2011.02.007_b0120","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1089\/aid.2006.0083","article-title":"Concurrent CMV and EBV DNAemia is significantly correlated with a delay in the response to HAART in treatment-naive HIV type 1-positive patients","volume":"23","author":"Panagiotakis","year":"2007","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.canlet.2011.02.007_b0125","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1177\/135965350601100104","article-title":"Long-term highly active antiretroviral therapy in chronic HIV-1 infection: evidence for reconstitution of antiviral immunity","volume":"11","author":"Jansen","year":"2006","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.canlet.2011.02.007_b0130","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0140-6736(03)12318-5","article-title":"New insights into EBV-associated post-transplant lymphoproliferative disease","volume":"361","author":"Rooney C","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.canlet.2011.02.007_b0135","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1034\/j.1399-3062.2001.003002060.x","article-title":"The Epstein\u2013Barr virus and post-transplant lymphoproliferative disease: interplay of immunosuppression, EBV, and the immune system in disease pathogenesis","volume":"3","author":"Tanner","year":"2001","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.canlet.2011.02.007_b0140","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.clim.2006.01.011","article-title":"Quantitative and functional defects of dendritic cells in classic Kaposi\u2019s sarcoma","volume":"119","author":"Della Bella","year":"2006","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.canlet.2011.02.007_b0145","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0092-8674(00)81431-2","article-title":"HIV-1 auxiliary proteins: making connections in a dying cell","volume":"93","author":"Cullen","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2011.02.007_b0150","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1023\/A:1021070512287","article-title":"HIV-1 replication","volume":"26","author":"Freed","year":"2001","journal-title":"Somat. Cell Mol. Genet."},{"key":"10.1016\/j.canlet.2011.02.007_b0155","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00705-008-0278-4","article-title":"The order Herpesvirales","volume":"154","author":"Davison","year":"2009","journal-title":"Arch. Virol."},{"key":"10.1016\/j.canlet.2011.02.007_b0160","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0037-1963(03)70002-X","article-title":"Molecular biology of Epstein\u2013Barr virus and Kaposi\u2019s sarcoma-associated herpesvirus","volume":"40","author":"Swaminathan","year":"2003","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.canlet.2011.02.007_b0165","first-page":"71","article-title":"TheRta\/Orf50 transactivator proteins of the gamma-herpesviridae","volume":"312","author":"Staudt","year":"2007","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.canlet.2011.02.007_b0170","doi-asserted-by":"crossref","first-page":"8532","DOI":"10.1128\/JVI.77.15.8532-8540.2003","article-title":"NF-kappaB inhibits gammaherpesvirus lytic replication","volume":"77","author":"Brown","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2011.02.007_b0175","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1023\/A:1008184330127","article-title":"Herpesvirus homologues of cellular genes","volume":"21","author":"Raftery","year":"2000","journal-title":"Virus Genes"},{"key":"10.1016\/j.canlet.2011.02.007_b0180","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1056\/NEJMra032015","article-title":"Persistence of the Epstein\u2013Barr virus and the origins of associated lymphomas","volume":"350","author":"A Thorley-Lawson","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2011.02.007_b0185","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jaci.2005.05.038","article-title":"EBV the prototypical human tumor virus \u2013 just how bad is it?","volume":"116","author":"Thorley-Lawson","year":"2005","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.canlet.2011.02.007_b0190","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1126\/science.7997879","article-title":"Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi\u2019s sarcoma","volume":"266","author":"Chang","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.canlet.2011.02.007_b0195","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1182\/blood.V86.4.1276.bloodjournal8641276","article-title":"Kaposi\u2019s sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman\u2019s disease","volume":"86","author":"Soulier","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2011.02.007_b0200","doi-asserted-by":"crossref","first-page":"8309","DOI":"10.1128\/JVI.72.10.8309-8315.1998","article-title":"A cluster of latently expressed genes in Kaposi\u2019s sarcoma-associated Herpesvirus","volume":"72","author":"Dittmer","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2011.02.007_b0205","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1006\/viro.1999.9672","article-title":"Transcriptional analysis of human herpesvirus-8 open reading frames 71, 72, 73, K14, and 74 in a primary effusion lymphoma cell line","volume":"257","author":"Talbot","year":"1999","journal-title":"Virology"},{"key":"10.1016\/j.canlet.2011.02.007_b0210","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1128\/JVI.73.2.1438-1446.1999","article-title":"Characterization and cell cycle regulation of the major Kaposi\u2019s sarcoma-associated herpesvirus (human herpesvirus 8) latent genes and their promoter","volume":"73","author":"Sarid","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2011.02.007_b0215","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1126\/science.284.5414.641","article-title":"Efficient persistence of extrachromosomal KSHV DNA Mediated by latency-associated nuclear antigen","volume":"284","author":"Ballestas","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.canlet.2011.02.007_b0220","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.1128\/JVI.75.7.3250-3258.2001","article-title":"Kaposi\u2019s sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mediates episome persistence through cis-acting terminal repeat (TR) sequence and specifically binds TR DNA","volume":"75","author":"Ballestas","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2011.02.007_b0225","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/47266","article-title":"p53 inhibition by the LANA protein of KSHV protects against cell death","volume":"402","author":"Friborg","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2011.02.007_b0230","doi-asserted-by":"crossref","first-page":"8019","DOI":"10.1128\/JVI.77.14.8019-8030.2003","article-title":"The latency-associated nuclear antigen of Kaposi\u2019s Sarcoma-associated herpesvirus manipulates the activity of glycogen synthase kinase-3\u03b2","volume":"77","author":"Fujimuro","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2011.02.007_b0235","doi-asserted-by":"crossref","first-page":"10429","DOI":"10.1128\/JVI.79.16.10429-10441.2005","article-title":"Regulation of the interaction between glycogen synthase kinase 3 and the Kaposi\u2019s Sarcoma-associated herpesvirus latency-associated nuclear antigen","volume":"79","author":"Fujimuro","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2011.02.007_b0240","doi-asserted-by":"crossref","first-page":"10348","DOI":"10.1128\/JVI.78.19.10348-10359.2004","article-title":"Latency-associated nuclear antigen of Kaposi\u2019s Sarcoma-associated herpesvirus up-regulates transcription of human telomerase reverse transcriptase promoter through interaction with transcription factor Sp1","volume":"78","author":"Verma","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2011.02.007_b0245","doi-asserted-by":"crossref","first-page":"22971","DOI":"10.1074\/jbc.M101890200","article-title":"The latency-associated nuclear antigen of Kaposi\u2019s sarcoma-associated herpesvirus transactivates the telomerase reverse transcriptase promoter","volume":"276","author":"Knight","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2011.02.007_b0250","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.molimm.2006.05.012","article-title":"In cis inhibition of antigen processing by the latency-associated nuclear antigen I of Kaposi sarcoma herpes virus","volume":"44","author":"Zaldumbide","year":"2007","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.canlet.2011.02.007_b0255","doi-asserted-by":"crossref","first-page":"8225","DOI":"10.1128\/JVI.00411-07","article-title":"Kaposi\u2019s sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mimics Epstein\u2013Barr virus EBNA1 immune evasion through central repeat domain effects on protein processing","volume":"81","author":"Kwun","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2011.02.007_b0260","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/386517a0","article-title":"Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors","volume":"386","author":"Thome","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2011.02.007_b0265","doi-asserted-by":"crossref","first-page":"24858","DOI":"10.1074\/jbc.M700118200","article-title":"Kaposi\u2019s Sarcoma-associated herpesvirus (KSHV) oncoprotein K13 bypasses TRAFs and directly interacts with the IkappaB kinase complex to selectively activate NF-kappaB without JNK activation","volume":"282","author":"Matta","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2011.02.007_b0270","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1084\/jem.20031467","article-title":"KSHV vFLIP is essential for the survival of infected lymphoma cells","volume":"199","author":"Guasparri","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.canlet.2011.02.007_b0275","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1182\/blood-2002-07-2072","article-title":"The human herpes virus 8-encoded viral FLICE inhibitory protein protects against growth factor withdrawal-induced apoptosis via NF-kappa B activation","volume":"101","author":"Sun","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2011.02.007_b0280","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1099\/vir.0.79812-0","article-title":"The cell cycle and how it is steered by Kaposi\u2019s sarcoma-associated herpesviruscyclin","volume":"85","author":"Verschuren","year":"2004","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.canlet.2011.02.007_b0285","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1002\/cncr.20309","article-title":"The changing pattern of Kaposi sarcoma in patients with HIV, 1994\u20132003. The EuroSIDA study","volume":"100","author":"Mocroft","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2011.02.007_b0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.bjc.6600745","article-title":"Review of the distribution of Kaposi\u2019s sarcoma-associated herpesvirus (KSHV) in Africa in relation to the incidence of Kaposi\u2019s sarcoma","volume":"88","author":"Dedicoat","year":"2003","journal-title":"Brit. J. Cancer"},{"key":"10.1016\/j.canlet.2011.02.007_b0295","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nrc2888","article-title":"Kaposi\u2019s sarcoma and its associated Herpesvirus","volume":"10","author":"Mesri","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2011.02.007_b0300","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1634\/theoncologist.12-5-569","article-title":"Primary effusion lymphoma","volume":"12","author":"Chen","year":"2007","journal-title":"Oncologist"},{"key":"10.1016\/j.canlet.2011.02.007_b0305","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.semcancer.2008.10.002","article-title":"Immune escape by Epstein\u2013Barr virus associated malignancies","volume":"18","author":"M\u00fcnz","year":"2008","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.canlet.2011.02.007_b0310","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.2217\/fmb.10.105","article-title":"Immune evasion by Kaposi\u2019s sarcoma-associated herpesvirus","volume":"5","author":"Lee","year":"2010","journal-title":"Future Microbiol."},{"key":"10.1016\/j.canlet.2011.02.007_b0315","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1086\/592170","article-title":"Progressive telomere shortening of Epstein\u2013Barr virus-specific memory T cells during HIV infection: contributor to exhaustion?","volume":"198","author":"van Baarle","year":"2008","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.canlet.2011.02.007_b0320","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1097\/00002030-200009080-00004","article-title":"Evaluation of the human herpesvirus 8 DNA load in blood and Kaposi\u2019s sarcoma skin lesions from AIDS patients on highly active antiretroviral therapy","volume":"14","author":"Boivin","year":"2000","journal-title":"AIDS"},{"key":"10.1016\/j.canlet.2011.02.007_b0325","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S1074-7613(00)80622-6","article-title":"EBV persistence in memory B cells in vivo","volume":"9","author":"Babcock","year":"1998","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2011.02.007_b0330","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1086\/508197","article-title":"Epstein\u2013Barr virus infects B and non-B lymphocytes in HIV-1-infected children and adolescents","volume":"194","author":"Bekker","year":"2006","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.canlet.2011.02.007_b0335","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1084\/jem.171.5.1791","article-title":"Complement receptor 2 mediates enhancement of human immunodeficiency virus 1 infection in Epstein\u2013Barr virus-carrying B cells","volume":"171","author":"Tremblay","year":"1990","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.canlet.2011.02.007_b0340","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.1128\/JVI.73.5.4181-4187.1999","article-title":"Cellular tropism and viral interleukin-6 expression distinguish human herpesvirus 8 involvement in Kaposi\u2019s sarcoma, primary effusion lymphoma, and multicentric Castleman\u2019s disease","volume":"73","author":"Staskus","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2011.02.007_b0345","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1056\/NEJMra032395","article-title":"Where does HIV live?","volume":"350","author":"Stebbing","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2011.02.007_b0350","doi-asserted-by":"crossref","first-page":"7963","DOI":"10.1128\/JVI.71.10.7963-7968.1997","article-title":"Monocytes in Kaposi\u2019s sarcoma lesions are productively infected by human herpesvirus 8","volume":"71","author":"Blasig","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2011.02.007_b0355","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1182\/blood-2003-07-2533","article-title":"HIV-1 Tat enhances Kaposi sarcoma-associated herpesvirus (KSHV) infectivity","volume":"104","author":"Aoki","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2011.02.007_b0360","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/ijc.10086","article-title":"HIV-1 infection of primary effusion lymphoma cell line triggers Kaposi\u2019s sarcoma-associated herpesvirus (KSHV) reactivation","volume":"97","author":"Merat","year":"2002","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2011.02.007_b0365","doi-asserted-by":"crossref","first-page":"785","DOI":"10.5858\/2001-125-0785-IOHIVR","article-title":"Induction of human immunodeficiency virus 1 replication by human herpesvirus 8","volume":"125","author":"Mercader","year":"2001","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.canlet.2011.02.007_b0370","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1182\/blood-2005-04-1390","article-title":"Human herpesvirus 8 enhances human immunodeficiency virus replication in acutely infected cells and induces reactivation in latently infected cells","volume":"106","author":"Caselli","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2011.02.007_b0375","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1128\/JVI.67.5.2853-2861.1993","article-title":"Epstein\u2013Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1","volume":"67","author":"Scala","year":"1993","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2011.02.007_b0380","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1089\/aid.1997.13.161","article-title":"Synergy between human immunodeficiency virus type 1 and Epstein\u2013Barr virus in T lymphoblastoid cell lines","volume":"13","author":"Zhang","year":"1997","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.canlet.2011.02.007_b0385","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.yexcr.2004.01.018","article-title":"Human immunodeficiency virus type 1 Tat protein modulates cell cycle and apoptosis in Epstein\u2013Barr virus-immortalized B cells","volume":"295","author":"Colombrino","year":"2004","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.canlet.2011.02.007_b0390","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1006\/bbrc.1993.2036","article-title":"The Epstein\u2013Barr virus DNA polymerase transactivates the human immunodeficiency virus type 1.5\u2032 long terminal repeat","volume":"195","author":"Lin","year":"1993","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.canlet.2011.02.007_b0395","doi-asserted-by":"crossref","first-page":"6496","DOI":"10.1128\/JVI.66.11.6496-6501.1992","article-title":"Epstein\u2013Barr virus latent membrane protein transactivates the human immunodeficiency virus type 1 long terminal repeat through induction of NF-kappa B activity","volume":"66","author":"Hammarskj\u00f6ld","year":"1992","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2011.02.007_b0400","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/0042-6822(89)90591-6","article-title":"Disparate effects of two herpesvirus [corrected] immediate-early gene trans-activators on the HIV-1 LTR","volume":"173","author":"Markovitz","year":"1989","journal-title":"Virology"},{"key":"10.1016\/j.canlet.2011.02.007_b0405","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1073\/pnas.85.5.1652","article-title":"An Epstein\u2013Barr virus immediate-early gene product trans-activates gene expression from the human immunodeficiency virus long terminal repeat","volume":"85","author":"Kenney","year":"1988","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2011.02.007_b0410","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1128\/JVI.64.4.1817-1820.1990","article-title":"The Epstein\u2013Barr virus BRLF1 immediate-early gene product transactivates the human immunodeficiency virus type 1 long terminal repeat by a mechanism which is enhancer independent","volume":"64","author":"Quinlivan","year":"1990","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2011.02.007_b0415","doi-asserted-by":"crossref","first-page":"6282","DOI":"10.1128\/JVI.64.12.6282-6285.1990","article-title":"The Epstein\u2013Barr virus BZLF1 gene product activates the human immunodeficiency virus type 1.5\u2032 long terminal repeat","volume":"64","author":"Mallon","year":"1990","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2011.02.007_b0420","doi-asserted-by":"crossref","first-page":"8761","DOI":"10.1128\/JVI.75.18.8761-8771.2001","article-title":"Latency-associated nuclear antigen encoded by Kaposi\u2019s Sarcoma-associated herpesvirus interacts with tat and activates the long terminal repeat of human immunodeficiency virus type 1 in human cells","volume":"75","author":"Hyun","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2011.02.007_b0425","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1128\/JVI.75.1.458-468.2001","article-title":"Modulation of cellular and viral gene expression by the latency-associated nuclear antigen of Kaposi\u2019s sarcoma-associated herpesvirus","volume":"75","author":"Renne","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2011.02.007_b0430","doi-asserted-by":"crossref","first-page":"13427","DOI":"10.1074\/jbc.M011314200","article-title":"Reciprocal regulatory interaction between human herpesvirus 8 and human immunodeficiency virus type 1","volume":"276","author":"Huang","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2011.02.007_b0435","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.tim.2010.04.001","article-title":"NF-kappaB signaling modulation by EBV and KSHV","volume":"18","author":"de Oliveira","year":"2010","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.canlet.2011.02.007_b0440","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1742-4690-2-9","article-title":"Kaposi\u2019s sarcoma associated herpes virus-encoded viral FLICE inhibitory protein activates transcription from HIV-1 long terminal repeat via the classical NF-kappaB pathway and functionally cooperates with Tat","volume":"2","author":"Sun","year":"2005","journal-title":"Retrovirology"},{"key":"10.1016\/j.canlet.2011.02.007_b0445","first-page":"956","article-title":"Gamma-interferon produced by CD8+ T cells infiltrating Kaposi\u2019s Sarcoma induces spindle cells with angiogenic phenotype and synergy with human immunodeficiency virus-1 Tat protein: an immune response to human herpesvirus-8 infection?","volume":"91","author":"Fiorelli","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2011.02.007_b0450","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/nm1296-1371","article-title":"The angiogenesis induced by HIV-1 tat protein is mediated by the Flk-1\/KDR receptor on vascular endothelial cells","volume":"2","author":"Albini","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2011.02.007_b0455","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/345084a0","article-title":"Tat protein of HIV-1 stimulates growth of cells derived from Kaposi\u2019s sarcoma lesions of AIDS patients","volume":"345","author":"Ensoli","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2011.02.007_b0460","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/371674a0","article-title":"Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi\u2019s sarcoma","volume":"371","author":"Ensoli","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2011.02.007_b0465","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/jnci\/92.9.721","article-title":"Human Kaposi\u2019s sarcoma cell-mediated tumorigenesis in human immunodeficiency type 1 tat-expressing transgenic mice","volume":"92","author":"Prakash","year":"2000","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.canlet.2011.02.007_b0470","doi-asserted-by":"crossref","first-page":"7941","DOI":"10.1073\/pnas.90.17.7941","article-title":"The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence","volume":"90","author":"Barillari","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2011.02.007_b0475","first-page":"663","article-title":"The Tat protein of human immunodeficiency virus type-1 promotes vascular cell growth and locomotion by engaging the alpha 5beta 1 and alpha vbeta 3 integrins and by mobilizing sequestered basic fibroblast growth factor","volume":"94","author":"Barillari","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2011.02.007_b0480","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1128\/JCM.29.6.1215-1220.1991","article-title":"Reactivation of Epstein\u2013Barr virus during early infection with human immunodeficiency virus","volume":"29","author":"Rahman","year":"1991","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.canlet.2011.02.007_b0485","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1023\/B:JOCI.0000019777.75784.6f","article-title":"Early impairment of CD8+ T cells immune response against Epstein\u2013Barr virus (EBV) antigens associated with high level of circulating mononuclear EBV DNA load in HIV infection","volume":"24","author":"Legoff","year":"2004","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.canlet.2011.02.007_b0490","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1749-6632.1992.tb24642.x","article-title":"Human immunodeficiency virus activates c-myc and Epstein\u2013Barr virus in human B lymphocytes","volume":"651","author":"Astrin","year":"1992","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.canlet.2011.02.007_b0495","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1099\/0022-1317-82-8-1965","article-title":"Human herpesvirus-8 (Kaposi\u2019s sarcoma-associated herpesvirus) ORF50 interacts synergistically with the tat gene product in transactivating the human immunodeficiency virus type 1 LTR","volume":"82","author":"Caselli","year":"2001","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.canlet.2011.02.007_b0500","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1099\/vir.0.18799-0","article-title":"Human herpesvirus-8 (Kaposi\u2019s sarcoma-associated virus) ORF50 increases in vitro cell susceptibility to human immunodeficiency virus type 1 infection","volume":"84","author":"Caselli","year":"2003","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.canlet.2011.02.007_b0505","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1006\/viro.2002.1434","article-title":"Human immunodeficiency virus type-1 activates lytic cycle replication of Kaposi\u2019s sarcoma-associated herpesvirus through induction of KSHV Rta","volume":"297","author":"Varthakavi","year":"2002","journal-title":"Virology"},{"key":"10.1016\/j.canlet.2011.02.007_b0510","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1128\/JVI.02024-06","article-title":"Intracellular Tat of human immunodeficiency virus type 1 activates lytic cycle replication of Kaposi\u2019s sarcoma-associated herpesvirus: role of JAK\/STAT signaling","volume":"81","author":"Zeng","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2011.02.007_b0515","doi-asserted-by":"crossref","first-page":"10329","DOI":"10.1128\/JVI.73.12.10329-10338.1999","article-title":"Human immunodeficiency virus replication in a primary effusion lymphoma cell line stimulates lytic-phase replication of Kaposi\u2019s sarcoma-associated Herpesvirus","volume":"73","author":"Varthakavi","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2011.02.007_b0520","doi-asserted-by":"crossref","first-page":"9336","DOI":"10.1128\/JVI.78.17.9336-9342.2004","article-title":"Tumorigenesis by human herpesvirus 8 vGPCR is accelerated by human immunodeficiency virus type 1 Tat","volume":"78","author":"Guo","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2011.02.007_b0525","doi-asserted-by":"crossref","first-page":"5759","DOI":"10.1128\/JVI.77.10.5759-5773.2003","article-title":"Human herpesvirus 8-encoded vGPCR activates nuclear factor of activated T cells and collaborates with human immunodeficiency virus type 1 Tat","volume":"77","author":"Pati","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2011.02.007_b0530","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1006\/viro.1999.0125","article-title":"Differential expression of the HHV-8 vGCR cellular homolog gene in AIDS-associated and classic Kaposi\u2019s sarcoma: potential role of HIV-1 Tat","volume":"267","author":"Yen-Moore","year":"2000","journal-title":"Virology"},{"key":"10.1016\/j.canlet.2011.02.007_b0535","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1593\/neo.09494","article-title":"Human immunodeficiency virus type 1 Tat accelerates Kaposi sarcoma-associated herpesvirusKaposin A-mediated tumorigenesis of transformed fibroblasts in vitro as well as in nude and immunocompetent mice","volume":"11","author":"Chen","year":"2009","journal-title":"Neoplasia"},{"key":"10.1016\/j.canlet.2011.02.007_b0540","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1128\/JVI.70.1.549-558.1996","article-title":"Primary characterization of a herpesvirus agent associated with Kaposi\u2019s sarcoma","volume":"70","author":"Moore","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2011.02.007_b0545","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1126\/science.278.5336.290","article-title":"Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines","volume":"278","author":"Boshoff","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.canlet.2011.02.007_b0550","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1182\/blood.V95.4.1151.004k37_1151_1157","article-title":"KSHV-encoded CC chemokine vMIP-III is a CCR4 agonist, stimulates angiogenesis, and selectively chemoattracts TH2 cells","volume":"95","author":"Stine","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2011.02.007_b0555","doi-asserted-by":"crossref","first-page":"e1569","DOI":"10.1371\/journal.pone.0001569","article-title":"Mutual inhibition between Kaposi\u2019s sarcoma-associated herpesvirus and Epstein\u2013Barr virus lytic replication initiators in dually-infected primary effusion lymphoma","volume":"3","author":"Jiang","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2011.02.007_b0560","doi-asserted-by":"crossref","first-page":"6068","DOI":"10.1128\/JVI.02743-06","article-title":"Epstein\u2013Barr virus inhibits Kaposi\u2019s sarcoma-associated herpesvirus lytic replication in primary effusion lymphomas","volume":"81","author":"Xu","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2011.02.007_b0565","doi-asserted-by":"crossref","first-page":"10488","DOI":"10.1128\/JVI.00894-10","article-title":"Convergence of Kaposi\u2019s sarcoma-associated herpesvirus reactivation with Epstein\u2013Barr virus latency and cellular growth mediated by the notch signaling pathway in coinfected cells","volume":"84","author":"Spadavecchia","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2011.02.007_b0575","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1126\/science.286.5438.300","article-title":"Mimicry of CD40 signals by Epstein\u2013Barr virus LMP1 in B lymphocyte responses","volume":"286","author":"Uchida","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.canlet.2011.02.007_b0580","doi-asserted-by":"crossref","first-page":"9637","DOI":"10.1128\/JVI.74.20.9637-9645.2000","article-title":"Human herpesvirus 8 LANA interacts with proteins of the mSin3 corepressor complex and negatively regulates Epstein\u2013Barr virus gene expression in dually infected PEL cells","volume":"74","author":"Krithivas","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2011.02.007_b0585","unstructured":"J.D. Novak, A.J. Ca\u00f1as, The Theory Underlying Concept Maps and How to Construct Them, Technical Report IHMC CmapTools 2006-01 Rev 01-2008, Florida Institute for Human and Machine Cognition, 2008. <http:\/\/cmap.ihmc.us\/Publications\/ResearchPapers\/TheoryUnderlyingConceptMaps.pdf>."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383511000802?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383511000802?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T18:22:09Z","timestamp":1685989329000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383511000802"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":116,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0304383511000802"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2011.02.007","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}